middle.news
How Lumos Secured Medicare Coverage for 70% of US FebriDx Tests
2:13am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
How Lumos Secured Medicare Coverage for 70% of US FebriDx Tests
2:13am on Monday 2nd of June, 2025 AEST
Key Points
Medicare reimbursement secured from fifth MAC, WPS Health Solutions
Coverage now spans five of seven MACs, representing 70%+ of US Medicare payments
Reimbursement rate set at US$41.38 per FebriDx test, retroactive to May 1, 2025
Negotiations ongoing with remaining two MACs to achieve full Medicare coverage
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Lumos Diagnostics Holdings (ASX:LDX)
OPEN ARTICLE